12
Participants
Start Date
May 31, 2016
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
oral treprostinil
Change in the Raynaud's Condition Score from baseline (2-week run in), comparing treprostinil treatment phase vs. placebo phase
Placebo
Placebo is a sugar pill manufactured to resemble UT-15C. Change in the Raynaud's Condition Score from baseline (2-week run in), comparing treprostinil treatment phase vs. placebo phase
Brigham and Women's Hospital, Boston
Collaborators (1)
United Therapeutics
INDUSTRY
Brigham and Women's Hospital
OTHER